Fractyl Health Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Fractyl Health Inc 's ROA in the second quarter of 2026?
Fractyl Health Inc recorded a cumulative net loss of $-106 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -101.33%.

However, within the Healthcare sector 740 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4292, from total ROA ranking in the first quarter of 2026 at 5091.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	32.21 %	19.68 %	48.11 %	14.77 %	-47.65 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-106	-108	-141	-122	-100
Return On Assets (TTM)	-101.33 %	-108.8 %	-148.09 %	-143.22 %	-122.2 %
GUTS's Total Ranking	# 4292	# 5091	# 4476	# 4474	# 4394
Total Assets (TTM) in million	82	99	121	114	62
Seq. Total Assets Change	-17.52 %	-18.14 %	6.24 %	84.29 %	-25.33 %
Seq. Net Income Change	-	-	-	-	-

GUTS's 5 Years Annual ROA >> Back to GUTS Management Effectiveness >> Compare GUTS ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 173
Sector	# 741
Overall	# 4226

Return On Assets Statistics
High	Average	Low
-50.42 %	-103.35 %	-148.09 %
(Dec 31 2024)		(Dec 31 2025)

Financial Statements
Fractyl Health Inc 's Assets	$ 82 million	GUTS's Balance sheet
Fractyl Health Inc 's Income	$ -26 million	Quarterly GUTS's Income Statement
GUTS's Income by Division		See GUTS's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	FY	FY	FY
Y / Y Total Assets Change	380.08 %	-	-	-	-
Total Assets in million	394	82	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-141	-69	0	0	0
Annual Return On Assets	-35.82 %	-83.81 %	-	-	-

GUTS's 5 Years Annual ROA >> Back to GUTS Management Effectiveness >> Compare GUTS ROA to its Competitors

More Return On Assets Ratios
GUTS's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
GUTS's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for GUTS's Competitors
Subscribers only: Roa for Fractyl Health Inc 's Suppliers
Subscribers only: Return On Assets for GUTS's Customers

You may also want to know
GUTS's Roi	GUTS's Inventory Turnover Ratio	GUTS's Growth Rates	GUTS's Dividend Comparisons
	GUTS's Profitability Ratios	GUTS's Asset Turnover Ratio	GUTS's Dividend Growth
GUTS's Roe	GUTS's Valuation Ratios	GUTS's Financial Strength Ratios	GUTS's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-26T07:43:05+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.